ContentsSynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferencesView all Images (11)
Hepatocellular carcinoma
Print Captions
Other Resources UpToDate PubMed

Hepatocellular carcinoma

Print Images (11)
Contributors: Beatriz Malibiran, Jennifer J. Findeis-Hosey MD
Other Resources UpToDate PubMed

Alerts and Notices

Synopsis

Hepatocellular carcinoma : Jaundice, Ascites, Hypoalbuminemia, Hyperbilirubinemia, Splenomegaly, PT prolonged, PLT decreased
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver in adults over the age of 65 years worldwide and is considered the third leading cause of cancer death. In the United States, the ratio of incidence of HCC between men and women is 2.5 to 1. The incidence and sex ratio of HCC varies regionally, and the majority of cases are diagnosed in developing nations. The incidence of HCC is highest in East Asia, Southeast Asia, and sub-Saharan Africa where disease is most commonly associated with chronic viral hepatitis B or C infection. Major risk factors for developing HCC include cirrhosis, chronic viral hepatitis, dietary aflatoxin, diabetes, nonalcoholic fatty liver disease (NAFLD), and alcohol abuse. Children are rarely affected; the only known risk factor in this population is chronic hepatitis B carrier status. In the United States, data suggests that the incidence of HCC may have remained stable since 2013, which may be attributed to improvements in antiviral therapy.

Patients are typically asymptomatic in the early stages of the disease. In the United States, right upper quadrant abdominal pain, weight loss, and malaise are common presenting symptoms. Jaundice, ascites, and hepatosplenomegaly may occur in patients with bile duct obstruction. Late findings include portal hypertension, abdominal bleeding, encephalopathy, and liver failure.

The Barcelona Clinic Liver Cancer algorithm is widely used for HCC staging:
  • Very early stage (0): Solitary nodules ≤ 2 cm. Treatment includes ablation or resection.
  • Early stage (A): Solitary nodule > 2 cm OR 2-3 nodules all ≤ 3 cm. Treatment options include resection, transplantation, or ablation.
  • Intermediate stage (B): > 3 nodules OR ≥ 2 nodules if any are > 3 cm. Treat with chemo-embolization.
  • Advanced stage (C): Macrovascular invasion OR extrahepatic spread. Treat with systemic therapies.
  • Terminal stage (D): End-stage liver function. Nontransplantable HCC. Supportive care.

Codes

ICD10CM:
C22.0 – Liver cell carcinoma

SNOMEDCT:
25370001 – Hepatocellular carcinoma

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed:04/27/2018
Last Updated:05/20/2020
Copyright © 2021 VisualDx®. All rights reserved.
Hepatocellular carcinoma
Captions Print   View all Images (11)
(with subscription)
Hepatocellular carcinoma : Jaundice, Ascites, Hypoalbuminemia, Hyperbilirubinemia, Splenomegaly, PT prolonged, PLT decreased
Imaging Studies image of Hepatocellular carcinoma
Grayscale ultrasound image of the liver demonstrating a heterogeneously hyperechoic mass in the right lobe of the liver. Pathology proven hepatocellular carcinoma.

+9 More images of Hepatocellular carcinoma with subscription

Copyright © 2021 VisualDx®. All rights reserved.